Science Translational Medicine
Science Translational Medicine is AAAS's translational journal, publishing the bench-to-bedside cancer papers on liquid biopsy, CAR-T engineering, tumour-immune biology and new imaging agents.
Science Translational Medicine appears weekly and publishes preclinical-to-early-clinical studies with strong mechanistic grounding, including early circulating tumour DNA detection methods, CAR-T design and toxicity work and PET tracer development. Subscription with delayed free access.
Defined EGFR resistance mechanisms in lung cancer and now leads early-detection research including the Sybil AI lung-risk model.
Built one of the first CD19 CAR-T programmes and invented 'armoured' CAR-T cells that secrete cytokines.
Developed the first antibody treatment for cancer, rituximab, and still works on training the immune system against lymphoma.
Nothing links here yet.